Lucy Lu

2018 - AVENUE THERAPEUTICS

In 2018, Lucy Lu earned a total compensation of $1.6M as Chief Executive Officer at AVENUE THERAPEUTICS, a 22% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$315,309
Salary$406,850
Stock Awards$865,000
Other$7,474
Total$1,594,633

Lu received $865K in stock awards, accounting for 54% of the total pay in 2018.

Lu also received $315.3K in non-equity incentive plan, $406.9K in salary and $7.5K in other compensation.

Rankings

In 2018, Lucy Lu's compensation ranked 6,873rd out of 14,244 executives tracked by ExecPay. In other words, Lu earned more than 51.7% of executives.

ClassificationRankingPercentile
All
6,873
out of 14,244
52nd
Division
Manufacturing
2,636
out of 5,765
54th
Major group
Chemicals And Allied Products
994
out of 2,128
53rd
Industry group
Drugs
835
out of 1,817
54th
Industry
Pharmaceutical Preparations
652
out of 1,391
53rd
Source: SEC filing on April 30, 2019.

Lu's colleagues

We found two more compensation records of executives who worked with Lucy Lu at AVENUE THERAPEUTICS in 2018.

2018

Joseph Vazzano

AVENUE THERAPEUTICS

Chief Financial Officer

2018

Scott Reines

AVENUE THERAPEUTICS

Chief Medical Officer

News

You may also like